Dara Mccreary, Phd Email & Phone Number

London, England, United Kingdom

In my various roles, I've collaborated closely with key business stakeholders to analyse our customers' scientific processes and workflows. Working across the EMEA region, my clients have ranged from National Hospitals and large international pharmaceutical businesses to small scientific startups. I've showcased my ability to effectively manage multiple customer discovery periods simultaneously.A significant part of my role has been to map out requirements and end-to-end processes… Show more In my various roles, I've collaborated closely with key business stakeholders to analyse our customers' scientific processes and workflows. Working across the EMEA region, my clients have ranged from National Hospitals and large international pharmaceutical businesses to small scientific startups. I've showcased my ability to effectively manage multiple customer discovery periods simultaneously.A significant part of my role has been to map out requirements and end-to-end processes, utilising appropriate tools for comprehensive documentation. I excel in analysing and understanding business processes, leading to the creation of both "as-is" and "to-be" process documentation. Additionally, I conduct gap analyses, identifying inconsistencies across mapped business processes and pinpointing opportunities for improvement.One of my strengths is facilitating and running deep dive sessions with customers. These sessions result in the production of workflows and documentation that empower Solutions Architects to configure the Sapio platform according to the specific needs of our customers. This experience has honed my skills in business change and process mapping analysis.Beyond my core responsibilities, I've actively contributed to pre-sales and marketing efforts within the business. I've also played a supportive role for my teammates, offering expertise in addressing science-based questions. My multifaceted experience underscores my adaptability and commitment to contributing to the business's and its clients' success. Open to connecting with like-minded professionals and exploring opportunities for collaboration. Show less

Abingdon, England, United Kingdom

During my tenure, I initiated and facilitated collaborative research endeavors with Key Opinion Leaders (KOLs) at two renowned cancer research institutions in the UK. This involved spearheading validation efforts for state-of-the-art Next-Generation Sequencing (NGS) technologies. Additionally, I devised comprehensive growth strategies for NGS technology, which encompassed the exploration of new markets and product avenues. Through meticulous market research and analysis, I identified consumer… Show more During my tenure, I initiated and facilitated collaborative research endeavors with Key Opinion Leaders (KOLs) at two renowned cancer research institutions in the UK. This involved spearheading validation efforts for state-of-the-art Next-Generation Sequencing (NGS) technologies. Additionally, I devised comprehensive growth strategies for NGS technology, which encompassed the exploration of new markets and product avenues. Through meticulous market research and analysis, I identified consumer needs, monitored technology trends, and forged strategic partnerships to bolster our market position. Acting as a pivotal point of contact, I delivered technical presentations and nurtured strong relationships with KOLs, customers, and distributors. Moreover, I played a pivotal role in driving cross-functional collaboration between sales and Research & Development (R&D) teams, ensuring alignment with market demands and optimizing product development processes. My involvement spanned across various facets of the business, including sales, marketing, user experience, and product development, contributing to the overall success and growth of the organization. Show less

London, United Kingdom

As principal scientist, I led the development of three research assays, significantly reducing diagnosis time from potentially years to days. Winning two Rosetree grants, our work resulted in two scientific papers and international presentations. Collaborating with KOLs in neurology and rheumatology, we designed assays meeting unmet clinical testing needs for over 300 patients, with diagnoses in over 40% of cases. These assays, including a rapid autoinflammation panel (NGS), neuroinflammation… Show more As principal scientist, I led the development of three research assays, significantly reducing diagnosis time from potentially years to days. Winning two Rosetree grants, our work resulted in two scientific papers and international presentations. Collaborating with KOLs in neurology and rheumatology, we designed assays meeting unmet clinical testing needs for over 300 patients, with diagnoses in over 40% of cases. These assays, including a rapid autoinflammation panel (NGS), neuroinflammation panel (NGS), and interferon assay (QPCR), were transferred to local NHS labs for routine use.I oversaw quality control and validation, including bioinformatics analysis. In challenging moments, I managed time and projects effectively, from sample collection to result return. Utilizing whole-exome sequencing (WES) bioinformatics (R programming & Command Prompt), I validated results and explored new disease discovery possibilities.I optimized internal procedures and pipelines, reducing turnaround times and increasing revenue through distributor negotiations. Maintaining transparent communication with stakeholders, I ensured alignment throughout. In internal departmental roles, including junior faculty and teaching assistant, I mentored MSc and PhD students, fostering a collaborative academic environment.Concluding my final year in this honorary position, I reflect on the significant contributions made to medical research and diagnostics, committed to driving further innovation in healthcare. Show less

London, England, United Kingdom

I actively contributed to multidisciplinary team meetings (MDTs), presenting clinical research data and offering insights to medical teams. Through collaboration with internal NHS genetic and bioinformatics researchers, I validated data from whole-exome and NGS-targeted panels, facilitating accurate patient diagnoses. My involvement in these processes underscores my commitment to advancing healthcare through collaborative research and data-driven insights.

Stanmore, England, United Kingdom

I conducted in-depth research into protein attachment on five commercially available bone graft substitutes (BGS), discerning variations influenced by the BGS chemistry and structures employed. Innovating novel techniques for protein removal and identification, I unveiled a diverse array of adherent proteins and their quantities, attributable to distinct BGS characteristics. Leveraging both primary and secondary data derived from mass spectrometry, I identified key proteins and advocated for… Show more I conducted in-depth research into protein attachment on five commercially available bone graft substitutes (BGS), discerning variations influenced by the BGS chemistry and structures employed. Innovating novel techniques for protein removal and identification, I unveiled a diverse array of adherent proteins and their quantities, attributable to distinct BGS characteristics. Leveraging both primary and secondary data derived from mass spectrometry, I identified key proteins and advocated for their pre-coating onto BGS through evidence-based research, potentially enhancing cellular attachment and osteoinduction. Presenting findings to BGS manufacturers resulted in significant research funding for our group. Additionally, I contributed to educational initiatives by auditing surgical lectures, recording, and editing content for the University's educational software, fostering knowledge dissemination within the academic community. Show less

Dublin, County Dublin, Ireland

I spearheaded the analysis of whole-exome sequencing (WES) data from 50 pediatric epilepsy patients, meticulously classifying disease-causing genes through variant calling and validation processes. Additionally, in a cohort of 13 patients, I successfully established a genetic linkage to a neurological syndrome, utilizing WES dataset interpretation and variant calling techniques. Presenting my findings to senior research and medical teams, I contributed valuable insights that informed clinical… Show more I spearheaded the analysis of whole-exome sequencing (WES) data from 50 pediatric epilepsy patients, meticulously classifying disease-causing genes through variant calling and validation processes. Additionally, in a cohort of 13 patients, I successfully established a genetic linkage to a neurological syndrome, utilizing WES dataset interpretation and variant calling techniques. Presenting my findings to senior research and medical teams, I contributed valuable insights that informed clinical decisions. Through single-family WES studies, I played a pivotal role in identifying novel disease-causing variants associated with neurocognitive deficits. Collaborating closely with senior researchers, I synthesized results and presented evidence-based research at multidisciplinary team (MDT) meetings, aiding in the formulation of informed opinions on gene variants for patient healthcare teams. The culmination of this research effort resulted in the publication of five articles in esteemed peer-reviewed journals, furthering scientific knowledge in the field. Show less

Dublin City, County Dublin, Ireland

Dublin, County Dublin, Ireland

For a busy concrete delivery company in charge of taking customer orders and ensuring deliveries were shipped in a timely manner.

Doctor Of Philosophy (Phd), Medical Science

Activities and Societies: UCL Lacrosse club player/coach. Developed novel techniques for the investigation of protein attachment to five.

Masters, Regenerative Medicine

Activities and Societies: Player/Coach of men's and women's lacrosse teams at the university. Masters research project: Investigated.

Honours Bachelor Of Science, Cell And Molecular Biology

Activities and Societies: UCD lacrosse. Final research project involved investigating: Evaluated the methylation status of the canine.